Skip to main content

Research Repository

Advanced Search

Study protocol for a randomised controlled trial assessing the clinical and cost-effectiveness of the Journeying through Dementia (JtD) intervention compared to usual care

Wright, Jessica; Foster, Alexis; Cooper, Cindy; Sprange, Kirsty; Walters, Stephen; Berry, Katherine; Moniz-Cook, Esme; Loban, Amanda; Young, Tracey Anne; Craig, Claire; Dening, Tom; Lee, Ellen; Beresford-Dent, Julie; Thompson, Benjamin John; Young, Emma; Thomas, Benjamin David; Mountain, Gail

Authors

Jessica Wright

Alexis Foster

Cindy Cooper

Kirsty Sprange

Stephen Walters

Katherine Berry

Profile Image

Professor Esme Moniz-Cook E.D.Moniz-Cook@hull.ac.uk
Emeritus Professor of Clinical Psychology of Ageing and Dementia Care Research / Dementia Research Work Group Lead

Amanda Loban

Tracey Anne Young

Claire Craig

Tom Dening

Ellen Lee

Julie Beresford-Dent

Benjamin John Thompson

Emma Young

Benjamin David Thomas

Gail Mountain



Abstract

Introduction
Services are being encouraged to provide postdiagnostic treatment to those with dementia but the availability of evidence-based interventions following diagnosis has not kept pace with increase in demand. To address this need, the Journeying through Dementia (JtD) intervention was created. A randomised controlled trial (RCT), based on a pilot study, is in progress.

Methods and analysis
The RCT is a pragmatic, two-arm, parallel group trial designed to test the clinical and cost-effectiveness of JtD compared with usual care. Recruitment will be through NHS services, third sector organisations and Join Dementia Research. The sample size is 486 randomised (243 to usual care and 243 to the intervention usual care). Participants can choose to ask a friend or relative (supporter) to become involved in the study. The primary outcome measure for participants is Dementia-Related Quality of Life (DEMQOL), collected at baseline and at 8 months’ postrandomisation. Secondary outcome measures will be collected from participants and supporters at those visits. Participants will also be followed up at 12 months’ postrandomisation with a reduced set of measures. A process evaluation will be conducted through qualitative and fidelity substudies. Analyses will compare the two arms of the trial on an intention to treat as allocated basis. The primary analyses will compare the mean DEMQOL scores of the participants at 8 months between the two study arms. A cost-effectiveness analysis will consider the incremental cost per Quality Adjusted Life Years of the intervention compared with usual care. Qualitative and fidelity substudies will be analysed through framework analysis and fidelity assessment tools respectively.

Ethics and dissemination
REC and HRA approval were obtained. A Data Monitoring and Ethics Committee has been constituted. Dissemination will be via publications, conferences and social media. Intervention materials will be made open access.

Citation

Wright, J., Foster, A., Cooper, C., Sprange, K., Walters, S., Berry, K., …Mountain, G. (2019). Study protocol for a randomised controlled trial assessing the clinical and cost-effectiveness of the Journeying through Dementia (JtD) intervention compared to usual care. BMJ open, 9(9), Article e029207. https://doi.org/10.1136/bmjopen-2019-029207

Journal Article Type Article
Acceptance Date Aug 9, 2019
Online Publication Date Sep 13, 2019
Publication Date 2019-09
Deposit Date Oct 9, 2019
Publicly Available Date Oct 10, 2019
Journal BMJ Open
Print ISSN 2044-6055
Electronic ISSN 2044-6055
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 9
Issue 9
Article Number e029207
DOI https://doi.org/10.1136/bmjopen-2019-029207
Public URL https://hull-repository.worktribe.com/output/2898357